Literature DB >> 20107185

Transcriptional regulation of the endogenous danger signal tenascin-C: a novel autocrine loop in inflammation.

Fui G Goh1, Anna M Piccinini, Thomas Krausgruber, Irina A Udalova, Kim S Midwood.   

Abstract

Inappropriate expression of proinflammatory mediators underpins the pathogenesis of autoimmune disease and tumor metastasis. The extracellular matrix glycoprotein tenascin-C is an endogenous activator of innate immunity that promotes the synthesis of inflammatory cytokines via activation of TLR4. Little tenascin-C is observed in most healthy adult tissues, but expression is specifically upregulated at sites of inflammation. Moreover, high levels of tenascin-C are associated with chronic inflammation and found in the tumor stroma. In this study, we show that the expression of tenascin-C is induced in immune myeloid cells activated by a variety of inflammatory stimuli, including specific TLR ligands. Its synthesis is transcriptionally regulated and requires the specific activation of AKT/PI3K and NF-kappaB signaling pathways. Using a bioinformatic approach, we identified a large number of conserved noncoding regions throughout the tenascin-C genomic locus that may contribute to its transcriptional regulation during inflammation. We also demonstrate that tenascin-C expression is transient during acute inflammation. In contrast, persistently high levels of expression occur in the inflamed synovium of joints from rheumatoid arthritis patients. Thus, misregulated expression of this endogenous danger signal may promote an autocrine loop of inflammation and contribute to the persistence of inflammation in autoimmune diseases or to tumor egress and invasion during metastasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20107185     DOI: 10.4049/jimmunol.0903359

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  64 in total

Review 1.  Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis.

Authors:  QiQuan Huang; Richard M Pope
Journal:  J Leukoc Biol       Date:  2010-05-19       Impact factor: 4.962

Review 2.  Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis.

Authors:  Jamie Campbell; David Lowe; Matthew A Sleeman
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

3.  High tenascin-C levels cause inadequate myocardial blush grade in patients with acute myocardial infarction.

Authors:  Ozlem Arican Ozluk; Dursun Topal; Erhan Tenekecioglu; Tezcan Peker; Mustafa Yilmaz; Kemal Karaagac; Fahriye Vatansever; Bedrettin Boyraz; Omur Aydın
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 4.  A complex interplay between the extracellular matrix and the innate immune response to microbial pathogens.

Authors:  Hannah Tomlin; Anna M Piccinini
Journal:  Immunology       Date:  2018-07-05       Impact factor: 7.397

5.  Tenascin-C expression is associated with poor prognosis in hepatocellular carcinoma (HCC) patients and the inflammatory cytokine TNF-α-induced TNC expression promotes migration in HCC cells.

Authors:  Yunhong Nong; Dongbo Wu; Yong Lin; Yongqiang Zhang; Lang Bai; Hong Tang
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

6.  Topographical changes in extracellular matrix: Activation of TLR4 signaling and solid tumor progression.

Authors:  Rhiannon M Kelsh; Paula J McKeown-Longo
Journal:  Trends Cancer Res       Date:  2013-01-01

7.  Distinct microenvironmental cues stimulate divergent TLR4-mediated signaling pathways in macrophages.

Authors:  Anna M Piccinini; Lorena Zuliani-Alvarez; Jenny M P Lim; Kim S Midwood
Journal:  Sci Signal       Date:  2016-08-30       Impact factor: 8.192

Review 8.  Tenascin-C Signaling in melanoma.

Authors:  Hanshuang Shao; John M Kirkwood; Alan Wells
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

9.  VARA attenuates hyperoxia-induced impaired alveolar development and lung function in newborn mice.

Authors:  Masheika L James; A Catharine Ross; Teodora Nicola; Chad Steele; Namasivayam Ambalavanan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-12       Impact factor: 5.464

Review 10.  Damage-associated molecular patterns and their receptors in upper airway pathologies.

Authors:  Koen Van Crombruggen; Fenila Jacob; Nan Zhang; Claus Bachert
Journal:  Cell Mol Life Sci       Date:  2013-05-15       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.